by Sue Robbins | Feb 7, 2020 | Miscellaneous
Craniosacral therapy (CST) may have major therapeutic benefits to those suffering from chronic pain, a new literature review published in BMC Musculoskeletal Disorders found. The literature review examined randomized controlled trials for craniosacral therapy (CST) in...
by Sue Robbins | Feb 5, 2020 | Migraine
Adults with Migraine have new reason to be hopeful. 2019 saw FDA approval of new acute Migraine medications, and 2020 will be the year thousands of adults with Migraine with or without aura will get to try new meds like Ubrelvy (ubreogepant). Ubrelvy is an oral CGRP...
by Sue Robbins | Jan 27, 2020 | Migraine
Treatment with the orally administered, small-molecule calcitonin gene-related peptide receptor antagonist ubrogepant in patients with acute migraine has been associated with freedom from pain and the absence of the patient-determined most troublesome symptom compared...
by Sue Robbins | Jan 16, 2020 | Migraine
Bodily injuries are an ever-present workplace hazard for professional athletes, a fact Philadelphia sports fans have been reminded of this week. Like Carson Wentz’s concussion that ended the Eagles’ playoff run and Sixers center Joel Embiid’s...
by Sue Robbins | Jan 15, 2020 | Migraine
A systematic review and meta-analysis of data collected from observational cohort studies reveals several clinical and sociodemographic factors are predictors of chronic migraine. The study, published in the International Headache Society’s Cephalalgia, looked at...
